Clinical Trial Update: Study to Determine the Safety and Tolerability of TG-C in Subjects with Back Pain Due to Degenerative Disc Disease [Phase 1]

View source ↗

Summary

This clinical trial update announces a Phase 1 study to assess the safety and tolerability of TG-C in back pain due to degenerative disc disease, which is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• TG-C (tissueGene-C)

Snippet

Sponsor: Kolon TissueGene, Inc. | Conditions: Degenerative Disc Disease | Phase 1 | Status: NOT_YET_RECRUITING